ICON Return on Investment 2011-2025 | ICLR
Current and historical return on investment (ROI) values for ICON (ICLR) over the last 10 years.
| ICON ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $0.81B | $12.21B | 6.38% |
| 2025-06-30 | $1.01B | $12.94B | 7.79% |
| 2025-03-31 | $1.03B | $12.89B | 7.94% |
| 2024-12-31 | $1.10B | $12.92B | 8.45% |
| 2024-09-30 | $1.07B | $13.18B | 8.21% |
| 2024-06-30 | $1.05B | $12.99B | 8.10% |
| 2024-03-31 | $1.02B | $12.85B | 7.93% |
| 2023-12-31 | $0.96B | $12.91B | 7.38% |
| 2023-09-30 | $0.89B | $12.87B | 6.87% |
| 2023-06-30 | $0.87B | $13.00B | 6.70% |
| 2023-03-31 | $0.84B | $13.01B | 6.44% |
| 2022-12-31 | $0.80B | $13.10B | 6.07% |
| 2022-09-30 | $0.74B | $13.03B | 5.59% |
| 2022-06-30 | $0.50B | $13.14B | 3.72% |
| 2022-03-31 | $0.43B | $13.16B | 4.04% |
| 2021-12-31 | $0.38B | $13.45B | 4.74% |
| 2021-09-30 | $0.35B | $13.84B | 6.84% |
| 2021-06-30 | $0.46B | $2.38B | 26.65% |
| 2021-03-31 | $0.40B | $2.28B | 35.79% |
| 2020-12-31 | $0.39B | $2.20B | 71.12% |
| 2020-09-30 | $0.39B | 0.00% | |
| 2020-06-30 | $0.39B | 82.25% | |
| 2020-03-31 | $0.44B | 46.43% | |
| 2019-12-31 | $0.43B | 31.28% | |
| 2019-09-30 | $0.42B | $1.89B | 23.20% |
| 2019-06-30 | $0.41B | $1.88B | 23.19% |
| 2019-03-31 | $0.38B | $1.77B | 22.76% |
| 2018-12-31 | $0.37B | $1.70B | 22.91% |
| 2018-09-30 | $0.36B | $1.68B | 22.75% |
| 2018-06-30 | $0.35B | $1.59B | 22.67% |
| 2018-03-31 | $0.35B | $1.55B | 23.20% |
| 2017-12-31 | $0.34B | $1.54B | 23.84% |
| 2017-09-30 | $0.33B | $1.48B | 24.55% |
| 2017-06-30 | $0.33B | $1.38B | 24.34% |
| 2017-03-31 | $0.32B | $1.29B | 24.59% |
| 2016-12-31 | $0.31B | $1.29B | 24.29% |
| 2016-09-30 | $0.30B | $1.39B | 24.38% |
| 2016-06-30 | $0.30B | $1.26B | 33.25% |
| 2016-03-31 | $0.29B | $1.19B | 50.37% |
| 2015-12-31 | $0.28B | $1.11B | 101.17% |
| 2015-09-30 | $0.26B | 0.00% | |
| 2015-06-30 | $0.25B | 0.00% | |
| 2015-03-31 | $0.23B | 0.00% | |
| 2014-12-31 | $0.20B | 0.00% | |
| 2014-09-30 | $0.18B | 0.00% | |
| 2014-06-30 | $0.15B | 0.00% | |
| 2014-03-31 | $0.14B | 0.00% | |
| 2013-12-31 | $0.22B | 0.00% | |
| 2013-09-30 | $0.21B | 0.00% | |
| 2013-06-30 | $0.20B | 0.00% | |
| 2013-03-31 | $0.19B | 0.00% | |
| 2012-12-31 | $0.16B | 0.00% | |
| 2012-09-30 | $0.15B | 0.00% | |
| 2012-06-30 | $0.13B | 0.00% | |
| 2012-03-31 | $0.13B | 0.00% | |
| 2011-12-31 | $0.12B | 0.00% | |
| 2011-09-30 | $0.22B | 0.00% | |
| 2011-06-30 | $0.24B | 0.00% | |
| 2011-03-31 | $0.25B | 0.00% | |
| 2010-12-31 | $0.18B | 0.00% | |
| 2010-09-30 | $0.10B | 0.00% | |
| 2010-06-30 | $0.11B | 79.72% | |
| 2010-03-31 | $0.12B | 41.95% | |
| 2009-12-31 | $0.12B | 28.28% | |
| 2009-09-30 | $0.29B | $0.57B | 52.89% |
| 2009-06-30 | $0.28B | $0.54B | 54.29% |
| 2009-03-31 | $0.18B | $0.54B | 35.26% |
| 2008-12-31 | $0.18B | $0.52B | 35.43% |
| 2008-09-30 | $-0.24B | $0.49B | -51.14% |
| 2008-06-30 | $-0.25B | $0.50B | -71.23% |
| 2008-03-31 | $-0.16B | $0.47B | -70.48% |
| 2007-12-31 | $-0.17B | $0.44B | -152.16% |
| 2007-09-30 | $0.06B | 84.49% | |
| 2007-06-30 | $0.06B | 76.57% | |
| 2007-03-31 | $0.05B | 69.97% | |
| 2006-12-31 | $0.05B | $0.30B | 63.37% |
| 2006-09-30 | $0.08B | 0.00% | |
| 2006-06-30 | $0.10B | 167.36% | |
| 2006-03-31 | $0.18B | 148.31% | |
| 2005-12-31 | $0.17B | 144.92% | |
| 2005-09-30 | $0.14B | $0.24B | 116.10% |
| 2005-06-30 | $0.15B | $0.23B | 128.95% |
| 2005-03-31 | $0.14B | 126.36% | |
| 2004-12-31 | $0.14B | 87.65% | |
| 2004-09-30 | $0.14B | $0.22B | 67.69% |
| 2004-06-30 | $0.10B | $0.22B | 66.24% |
| 2004-03-31 | $0.09B | $0.21B | 67.03% |
| 2003-12-31 | $0.11B | $0.20B | 128.96% |
| 2003-09-30 | $0.11B | 307.25% | |
| 2003-06-30 | $0.10B | $0.14B | 298.55% |
| 2003-03-31 | $0.08B | 0.00% | |
| 2002-12-31 | $0.11B | 0.00% | |
| 2002-09-30 | $0.14B | 0.00% | |
| 2002-06-30 | $0.17B | 0.00% | |
| 2002-03-31 | $0.16B | 731.03% | |
| 2001-12-31 | $0.14B | 625.29% | |
| 2001-09-30 | $0.13B | 583.91% | |
| 2001-06-30 | $0.12B | $0.09B | 537.93% |
| 2001-03-31 | $0.11B | 555.84% | |
| 2000-12-31 | $0.10B | 509.09% | |
| 2000-09-30 | $0.09B | 457.14% | |
| 2000-06-30 | $0.08B | $0.08B | 415.58% |
| 1999-12-31 | $0.06B | 311.11% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.220B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.894B | 27.52 |
| HCA Healthcare (HCA) | United States | $107.981B | 17.88 |
| CVS Health (CVS) | United States | $99.714B | 11.47 |
| Elevance Health (ELV) | United States | $70.690B | 10.37 |
| Cencora (COR) | United States | $68.633B | 22.14 |
| Natera (NTRA) | United States | $27.439B | 0.00 |
| DiDi Global (DIDIY) | China | $24.144B | 19.73 |
| Labcorp Holdings (LH) | United States | $20.782B | 15.85 |
| Medpace Holdings (MEDP) | United States | $16.867B | 41.88 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.984B | 0.00 |
| Viatris (VTRS) | United States | $12.411B | 4.46 |
| CochLear (CHEOY) | Australia | $12.126B | 0.00 |
| Solventum (SOLV) | United States | $11.737B | 12.11 |
| Revvity (RVTY) | United States | $10.495B | 19.33 |
| Charles River Laboratories (CRL) | United States | $8.253B | 15.90 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.215B | 0.00 |
| HealthEquity (HQY) | United States | $8.132B | 32.55 |
| Avantor (AVTR) | United States | $7.895B | 12.06 |
| Sonic Healthcare (SKHHY) | Australia | $6.712B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.894B | 35.14 |
| Bausch + Lomb (BLCO) | Canada | $5.571B | 36.58 |
| Sotera Health (SHC) | United States | $4.492B | 21.66 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 22.50 |
| GeneDx Holdings (WGS) | United States | $3.932B | 69.48 |
| Alignment Healthcare (ALHC) | United States | $3.414B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.815B | 35.42 |
| Concentras Parent (CON) | United States | $2.453B | 15.56 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.099B | 8.10 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.863B | 11.12 |
| Establishment Labs Holdings (ESTA) | $1.753B | 0.00 | |
| Organon (OGN) | United States | $1.659B | 1.81 |
| Progyny (PGNY) | United States | $1.623B | 34.33 |
| Teladoc Health (TDOC) | United States | $1.430B | 0.00 |
| Omada Health (OMDA) | $1.342B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.157B | 18.50 |
| CareDx (CDNA) | United States | $0.850B | 13.89 |
| Embecta (EMBC) | United States | $0.811B | 4.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 9.78 |
| Nutex Health (NUTX) | United States | $0.730B | 11.05 |
| Pomdoctor - (POM) | China | $0.614B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.556B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.541B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
| CryoPort (CYRX) | United States | $0.427B | 0.00 |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.416B | 18.66 |
| Auna S.A (AUNA) | Luxembourg | $0.402B | 6.03 |
| Charming Medical (MCTA) | $0.383B | 0.00 | |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.377B | 0.00 |
| KindlyMD (NAKA) | United States | $0.355B | 0.00 |
| SBC Medicals (SBC) | United States | $0.330B | 7.23 |
| Agilon Health (AGL) | United States | $0.312B | 0.00 |
| LifeMD (LFMD) | United States | $0.267B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.230B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.116B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.97 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |